Kongtana TrakarnsangaRebecca E. GriffithsMarieangela C. WilsonAllison BlairTimothy J. SatchwellMarjolein MeindersNicola CoganSabine KupzigRyo KuritaYukio NakamuraAshley M. ToyeDavid J. AnsteeJan FrayneUniversity of BristolMahidol UniversityNHS Blood and TransplantJapanese Red Cross Medical CenterRiken BioResource Center2018-12-212019-03-142018-12-212019-03-142017-03-14Nature Communications. Vol.8, (2017)204117232-s2.0-85015185953https://repository.li.mahidol.ac.th/handle/20.500.14594/41934© 2017 The Author(s). With increasing worldwide demand for safe blood, there is much interest in generating red blood cells in vitro as an alternative clinical product. However, available methods for in vitro generation of red cells from adult and cord blood progenitors do not yet provide a sustainable supply, and current systems using pluripotent stem cells as progenitors do not generate viable red cells. We have taken an alternative approach, immortalizing early adult erythroblasts generating a stable line, which provides a continuous supply of red cells. The immortalized cells differentiate efficiently into mature, functional reticulocytes that can be isolated by filtration. Extensive characterization has not revealed any differences between these reticulocytes and in vitro-cultured adult reticulocytes functionally or at the molecular level, and importantly no aberrant protein expression. We demonstrate a feasible approach to the manufacture of red cells for clinical use from in vitro culture.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyChemistryArticleSCOPUS10.1038/ncomms14750